[go: up one dir, main page]

MXPA05012319A - Suministro de compuestos con celulas sanguineas rehidratadas. - Google Patents

Suministro de compuestos con celulas sanguineas rehidratadas.

Info

Publication number
MXPA05012319A
MXPA05012319A MXPA05012319A MXPA05012319A MXPA05012319A MX PA05012319 A MXPA05012319 A MX PA05012319A MX PA05012319 A MXPA05012319 A MX PA05012319A MX PA05012319 A MXPA05012319 A MX PA05012319A MX PA05012319 A MXPA05012319 A MX PA05012319A
Authority
MX
Mexico
Prior art keywords
blood cells
compounds
supply
rehydrated blood
rehydrated
Prior art date
Application number
MXPA05012319A
Other languages
English (en)
Inventor
Marjorie S Read
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Publication of MXPA05012319A publication Critical patent/MXPA05012319A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/124—Disinfecting agents, e.g. antimicrobials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/905—Specially adapted for travel through blood circulatory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se describen celulas sanguineas fijadas-secas que portan un agente activo, junto con metodos para hacer las mismas, metodos para utilizar las mismas, y composiciones que contienen a las mismas; las celulas sanguineas pueden ser globulos rojos o plaquetas sanguineas.
MXPA05012319A 2003-05-16 2004-05-14 Suministro de compuestos con celulas sanguineas rehidratadas. MXPA05012319A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US47100503P 2003-05-16 2003-05-16
US53305903P 2003-12-29 2003-12-29
US10/845,045 US7294455B2 (en) 2003-05-16 2004-05-13 Fixed-dried platelets cross-linked to protein
PCT/US2004/015320 WO2005021706A2 (en) 2003-05-16 2004-05-14 Delivery of compounds with rehydrated blood cells

Publications (1)

Publication Number Publication Date
MXPA05012319A true MXPA05012319A (es) 2006-01-30

Family

ID=34279762

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05012319A MXPA05012319A (es) 2003-05-16 2004-05-14 Suministro de compuestos con celulas sanguineas rehidratadas.

Country Status (7)

Country Link
US (5) US7294455B2 (es)
EP (1) EP1624752A4 (es)
JP (1) JP2006525810A (es)
CN (1) CN1822765B (es)
CA (1) CA2525374A1 (es)
MX (1) MXPA05012319A (es)
WO (1) WO2005021706A2 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7294455B2 (en) * 2003-05-16 2007-11-13 The University Of North Carolina At Chapel Hill Fixed-dried platelets cross-linked to protein
US8277837B2 (en) 2006-01-11 2012-10-02 Entegrion, Inc. Hemostatic textile
US20070178107A1 (en) * 2006-01-31 2007-08-02 Awdalla Essam T Method and means for treating solid tumors
CN104083757A (zh) * 2007-04-06 2014-10-08 武田疫苗公司 用于活的减毒病毒的方法和组合物
US8512697B2 (en) * 2007-05-16 2013-08-20 The University Of North Carolina At Chapel Hill Delivery of micro- and nanoparticles with blood platelets
WO2009111615A2 (en) * 2008-03-05 2009-09-11 Thrombovision, Inc. Systems for measuring properties of a physiological fluid suspension
WO2015009897A1 (en) 2013-07-17 2015-01-22 Rythrx Therapeutics, Llc Compositions and methods for preserving red blood cells and platelets
WO2015061206A2 (en) 2013-10-21 2015-04-30 North Carolina State University Methods and constructs for compound delivery
WO2015109220A1 (en) * 2014-01-17 2015-07-23 President And Fellows Of Harvard College Platelet decoy and use thereof
CN106461327B (zh) 2014-06-09 2019-12-13 泰尔茂比司特公司 冻干法
US10391491B2 (en) * 2014-08-07 2019-08-27 The General Hospital Corporation Platelet-targeted microfluidic isolation of cells
CA3005311A1 (en) * 2014-11-14 2016-05-19 Cellphire, Inc. Products and devices for controlling and stopping bleeding and methods of using
EP3512554B1 (en) * 2016-09-13 2022-07-27 North Carolina State University Platelet compositions and methods for the delivery of therapeutic agents
MX2019006354A (es) * 2016-11-30 2019-10-21 Univ Miami Composicion de microparticulas derivadas de globulos rojos (rmp) y metodos de uso.
CA3078625C (en) 2017-10-09 2023-01-17 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
AU2019387368A1 (en) 2018-11-30 2021-06-17 Cellphire, Inc. Platelets as delivery agents
US11767511B2 (en) 2018-11-30 2023-09-26 Cellphire, Inc. Platelets as delivery agents
CN113597532B (zh) 2019-03-14 2023-02-17 泰尔茂比司特生物技术有限公司 冻干容器填充固定装置、系统及使用方法
KR20220016092A (ko) 2019-05-03 2022-02-08 셀파이어, 인크. 혈액 생성물을 생산하기 위한 물질 및 방법
WO2021034719A1 (en) 2019-08-16 2021-02-25 Cellphire, Inc. Thrombosomes as an antiplatelet agent reversal agent
CA3170134A1 (en) 2020-02-04 2021-08-12 Cellphire, Inc. Treatment of von willebrand disease
CN112656763B (zh) * 2020-12-29 2022-07-15 吉林大学 一种基于剪切力响应的载药纳米胶束的制备方法
TW202245814A (zh) 2021-02-17 2022-12-01 美商賽菲爾公司 用於治療抗血小板誘導的凝血病之凍乾血小板衍生物組成物
CN118743768A (zh) * 2024-06-13 2024-10-08 浙江大学 一种血小板-aav包装复合体及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2051092C (en) * 1990-09-12 2002-07-23 Stephen A. Livesey Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions
DE69332756T2 (de) 1992-05-29 2004-02-19 University Of North Carolina At Chapel Hill Im immobilisierten zustand getrocknete pharmazeutische verträgliche menschliche blutplättchen
JPH08109142A (ja) * 1994-08-16 1996-04-30 S R L:Kk 血小板薬物送達システム
AR001654A1 (es) 1995-04-19 1997-11-26 Univ East Carolina Método para la descontaminacion microbiana de plaquetas sanguineas
US5891393A (en) * 1996-04-09 1999-04-06 The University Of North Carolina At Chapel Hill Method for the microbial decontamination of blood platelets
AT407484B (de) 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AU752330B2 (en) 1998-01-06 2002-09-19 Trustees Of Boston University Decorated red blood cells
US6139878A (en) 1998-04-27 2000-10-31 Aventis Behring, Llc Method for preparing a diafiltered stabilized blood product
WO2001058266A1 (en) * 2000-02-10 2001-08-16 The Regents Of The University Of California Therapeutic platelets and methods
US6770478B2 (en) * 2000-02-10 2004-08-03 The Regents Of The University Of California Erythrocytic cells and method for preserving cells
JP2001333771A (ja) * 2000-03-24 2001-12-04 Olympus Optical Co Ltd 固相組織又は細胞の乾燥固定方法
US6884573B2 (en) * 2001-08-31 2005-04-26 The University Of North Carolina At Chapel Hill Fixed dried red blood cells and method of use
US7294455B2 (en) * 2003-05-16 2007-11-13 The University Of North Carolina At Chapel Hill Fixed-dried platelets cross-linked to protein
DE102004054536A1 (de) * 2004-11-06 2006-05-11 Capsulution Nanoscience Ag Multimodal veränderte Zellen als zellulare Darreichungsformen für aktive Substanzen und als diagnostische Zellpartikel

Also Published As

Publication number Publication date
US7901674B2 (en) 2011-03-08
US20120128647A1 (en) 2012-05-24
AU2004269308B2 (en) 2009-09-17
EP1624752A4 (en) 2007-07-11
US8492081B2 (en) 2013-07-23
US20140065120A1 (en) 2014-03-06
CA2525374A1 (en) 2005-03-10
AU2004269308A1 (en) 2005-03-10
WO2005021706A3 (en) 2005-12-15
WO2005021706A2 (en) 2005-03-10
US20070212300A1 (en) 2007-09-13
US7294455B2 (en) 2007-11-13
US20050025748A1 (en) 2005-02-03
EP1624752A2 (en) 2006-02-15
CN1822765B (zh) 2011-08-17
US20050272161A1 (en) 2005-12-08
JP2006525810A (ja) 2006-11-16
CN1822765A (zh) 2006-08-23

Similar Documents

Publication Publication Date Title
MXPA05012319A (es) Suministro de compuestos con celulas sanguineas rehidratadas.
ATE508190T1 (de) Mehrfachpromotor-expressionskassetten zurgleichzeitigen zuführung von rnai-agentien
ECSP088152A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
GT200600407A (es) Compuestos ppar activos
CY1116768T1 (el) Συνθεσεις οι οποιες περιεχουν βλαστοκυτταρα θηλυκης γαμετικης σειρας και μεθοδοι χρησης αυτων
BR0215405A (pt) Composições e processos de uso de collajolie
AR043150A1 (es) Composicion oral que contiene enzimas con estabilidad mejorada
NO20083940L (no) Fremgangsmater for redusering av proteinaggregering
BRPI0317696B8 (pt) composição para branqueamento
ECSP088252A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
CL2009001474A1 (es) Procedimiento para tratar mineral sulfurado que comprende biolixiviar en solucion de iones cl- con un consorcio de cultivos mixtos de leptosprillium ferriphilum y microorganismo oxidante de azufre, halofilico o halotolerante, donde la solucion contiene 1500-30000 ppm de cl- y ademas contiene al, mg o na, a t>10 grados y ph 1-3.
BR0307935A (pt) Sais de trans carotenóide bipolares e seus usos
BRPI0412989A (pt) combinação farmacêutica útil para mobilização de célula-tronco
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
AU2002317501A1 (en) Antiobestic and/or antidiabetic agent containing cyanidin 3-glucoside as active ingredient
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
AR052339A1 (es) Formulaciones terapeuticas del factor de crecimiento queratinocitico
AR038560A1 (es) Una composicion antitranspirante/ desodorante
BR0314402A (pt) Expansão ex-vivo de populações de células raìzes em culturas celulares mononucleares
AR037437A1 (es) Composicion de cateter y sus usos. envase de compartimentos multiples y cateter
BRPI0406744A (pt) Artigo absorvente de higiene feminina
PT1627566E (pt) Bolsa de segurança para a crioconservação de células estaminais ou componentes sanguíneos semelhantes
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
FR2883184B1 (fr) Composition de spirulines riche en principes actifs, procede d'obtention et utilisation
SE0103765D0 (sv) New use

Legal Events

Date Code Title Description
FG Grant or registration